Atrium Therapeutics Inc (RNA)

Deferred Revenue

$9.04M

Quarterly · Period ending: · USD

RNA logo

RNA Deferred Revenue

Latest reported$9.04M
RNA Quarterly Deferred Revenue ($19.12M → $9.04M)
High-resolution chart · PNG

RNA deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
9,038,000
9,344,000
21,639,000
19,123,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.